CJA36122

Caenorhabditis japonica

Is predicted to encode a protein with the following domains: RLI1; Possible Fer4-like domain in RNase L inhibitor, RLI; 4Fe-4S binding domain; RNase L inhibitor RLI-like, possible metal-binding domain; and 4Fe-4S ferredoxin-type, iron-sulphur binding domain. Is an ortholog of C. elegans abce-1.

Cjp-ciao-1

Caenorhabditis japonica

Predicted to be involved in iron-sulfur cluster assembly. Predicted to be part of cytosolic [4Fe-4S] assembly targeting complex. Is an ortholog of C. elegans ciao-1.

Cjp-lin-36

Caenorhabditis japonica

Is an ortholog of C. elegans lin-36. In C. elegans, lin-36 is involved in embryonic digestive tract morphogenesis.

Cjp-lin-65

Caenorhabditis japonica

Is an ortholog of C. elegans lin-65. In C. elegans, lin-65 is involved in chromatin remodeling and mitochondrial unfolded protein response.

Cjp-lin-33

Caenorhabditis japonica

Is an ortholog of C. elegans lin-33.

Cjp-lin-25

Caenorhabditis japonica

Is an ortholog of C. elegans lin-25. In C. elegans, lin-25 is involved in defense response to Gram-positive bacterium and vulval development.

CJA14653

Caenorhabditis japonica

Is an ortholog of C. elegans lin-66. In C. elegans, lin-66 is involved in negative regulation of gene expression and regulation of development, heterochronic.

Cjp-lin-46

Caenorhabditis japonica

Predicted to be involved in molybdopterin cofactor biosynthetic process. Is an ortholog of C. elegans lin-46. In C. elegans, lin-46 is involved in regulation of development, heterochronic.

Cjp-lin-54

Caenorhabditis japonica

Is predicted to encode a protein with the following domains: Lin-54 family; CRC domain; Tesmin/TSO1-like CXC domain; and Tesmin/TSO1-like CXC domain, cysteine-rich domain. Is an ortholog of C. elegans lin-54. In C. elegans, lin-54 is involved in negative regulation of vulval development.

Cjp-lin-26

Caenorhabditis japonica

Is an ortholog of C. elegans lin-26. In C. elegans, lin-26 is involved in several processes, including positive regulation of transcription by RNA polymerase II; tissue development; and vulval development.